EASTBOURNE CAPITAL MANAGEMENT LLC/CA Insider Trading $AMLN AMYLIN PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for EASTBOURNE CAPITAL MANAGEMENT LLC/CA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of EASTBOURNE CAPITAL MANAGEMENT LLC/CA. EASTBOURNE CAPITAL MANAGEMENT LLC/CA is 10% Owner in AMYLIN PHARMACEUTICALS INC ($AMLN) and 10% Owner in MGIC INVESTMENT CORP ($MTG) and 10% Owner in Sarepta Therapeutics, Inc. ($SRPT) and 10% Owner in PAIN THERAPEUTICS INC ($PTIE) and 10% Owner in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX).
EASTBOURNE CAPITAL MANAGEMENT LLC/CA in AMYLIN PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of EASTBOURNE CAPITAL MANAGEMENT LLC/CA: 10% Owner
Holdings: 13,346,120 shares
Latest Transaction: Sep 18 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of EASTBOURNE CAPITAL MANAGEMENT LLC/CA in AMYLIN PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMLN, SAVA, MBVX, MTG, SRPT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 13.89 | 428,574 | 5,953,750 | 13,346,120 | 13.8 M to 13.3 M (-3.11 %) |
| Sep 18 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 13.93 | 180,000 | 2,506,806 | 13,774,694 | 14 M to 13.8 M (-1.29 %) |
| Sep 18 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 13.96 | 475,000 | 6,631,238 | 13,954,694 | 14.4 M to 14 M (-3.29 %) |
| Sep 18 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 13.99 | 305,711 | 4,277,478 | 14,429,694 | 14.7 M to 14.4 M (-2.07 %) |
| Sep 18 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 13.98 | 3,100 | 43,323 | 14,735,405 | 14.7 M to 14.7 M (-0.02 %) |
| Sep 18 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 13.98 | 22,500 | 314,550 | 14,738,505 | 14.8 M to 14.7 M (-0.15 %) |
| Sep 18 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 14.01 | 28,356 | 397,228 | 14,761,005 | 14.8 M to 14.8 M (-0.19 %) |
| Sep 18 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 14.09 | 300,000 | 4,225,500 | 14,789,361 | 15.1 M to 14.8 M (-1.99 %) |
| Sep 18 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 14.12 | 62,200 | 878,519 | 15,089,361 | 15.2 M to 15.1 M (-0.41 %) |
| Sep 18 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 14.15 | 284,900 | 4,032,133 | 15,151,561 | 15.4 M to 15.2 M (-1.85 %) |
| Sep 18 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 14.11 | 483,402 | 6,822,107 | 15,436,461 | 15.9 M to 15.4 M (-3.04 %) |
| Sep 18 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 14.31 | 17,437 | 249,525 | 15,919,863 | 15.9 M to 15.9 M (-0.11 %) |
| Sep 18 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 14.13 | 796,400 | 11,252,017 | 15,937,300 | 16.7 M to 15.9 M (-4.76 %) |
| Sep 18 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 14.22 | 466,300 | 6,628,688 | 16,733,700 | 17.2 M to 16.7 M (-2.71 %) |
| Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 21.77 | 1,000,000 | 21,770,000 | 17,200,000 | 18.2 M to 17.2 M (-5.49 %) |
| Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 21.58 | 180,321 | 3,891,327 | 18,200,000 | 18.4 M to 18.2 M (-0.98 %) |
| Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 21.23 | 3,904,541 | 82,893,405 | 18,380,321 | 22.3 M to 18.4 M (-17.52 %) |
| Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 21.05 | 691,700 | 14,560,285 | 22,284,862 | 23 M to 22.3 M (-3.01 %) |
| Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 20.28 | 50,000 | 1,014,000 | 22,976,562 | 23 M to 23 M (-0.22 %) |
| Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 20.07 | 200,000 | 4,014,000 | 23,026,562 | 23.2 M to 23 M (-0.86 %) |
| Jun 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.93 | 125,000 | 3,741,250 | 23,226,562 | 23.1 M to 23.2 M (+0.54 %) |
| Jun 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.91 | 25,000 | 747,750 | 23,101,562 | 23.1 M to 23.1 M (+0.11 %) |
| May 08 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 27.91 | 27,100 | 756,361 | 23,076,562 | 23 M to 23.1 M (+0.12 %) |
| May 08 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 27.91 | 193,406 | 5,397,961 | 23,049,462 | 22.9 M to 23 M (+0.85 %) |
| May 08 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 27.88 | 29,494 | 822,293 | 22,856,056 | 22.8 M to 22.9 M (+0.13 %) |
| May 01 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 27.72 | 356,652 | 9,886,393 | 22,826,562 | 22.5 M to 22.8 M (+1.59 %) |
| Apr 22 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.55 | 24,100 | 712,155 | 22,469,910 | 22.4 M to 22.5 M (+0.11 %) |
| Apr 22 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 28.52 | 869,900 | 24,809,548 | 22,445,810 | 21.6 M to 22.4 M (+4.03 %) |
| Apr 17 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.35 | 50,000 | 1,517,500 | 21,575,901 | 21.5 M to 21.6 M (+0.23 %) |
| Apr 17 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.78 | 19,471 | 599,317 | 21,525,901 | 21.5 M to 21.5 M (+0.09 %) |
| Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.30 | 27,389 | 802,498 | 21,506,439 | 21.5 M to 21.5 M (+0.13 %) |
| Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.24 | 1,300 | 38,012 | 21,479,050 | 21.5 M to 21.5 M (+0.01 %) |
| Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.47 | 66,913 | 1,971,926 | 21,477,750 | 21.4 M to 21.5 M (+0.31 %) |
| Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.41 | 77,695 | 2,285,010 | 21,410,837 | 21.3 M to 21.4 M (+0.36 %) |
| Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.37 | 2,700 | 79,299 | 21,333,142 | 21.3 M to 21.3 M (+0.01 %) |
| Apr 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.09 | 82,967 | 2,496,477 | 21,330,442 | 21.2 M to 21.3 M (+0.39 %) |
| Apr 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.07 | 64,970 | 1,953,648 | 21,247,475 | 21.2 M to 21.2 M (+0.31 %) |
| Apr 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.97 | 6,000 | 179,820 | 21,182,505 | 21.2 M to 21.2 M (+0.03 %) |
| Apr 11 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.80 | 137,363 | 4,093,417 | 21,176,505 | 21 M to 21.2 M (+0.65 %) |
| Apr 09 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.05 | 208,700 | 6,271,435 | 21,039,142 | 20.8 M to 21 M (+1.00 %) |
| Apr 09 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.96 | 50,000 | 1,548,000 | 20,830,442 | 20.8 M to 20.8 M (+0.24 %) |
| Apr 09 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 31.52 | 50,000 | 1,576,000 | 20,780,442 | 20.7 M to 20.8 M (+0.24 %) |
| Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.61 | 103,800 | 3,177,318 | 20,730,442 | 20.6 M to 20.7 M (+0.50 %) |
| Apr 04 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.50 | 51,200 | 1,561,600 | 20,626,642 | 20.6 M to 20.6 M (+0.25 %) |
| Mar 28 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 28.10 | 118,933 | 3,342,017 | 20,575,442 | 20.5 M to 20.6 M (+0.58 %) |
| Mar 26 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 28.08 | 31,067 | 872,361 | 20,456,509 | 20.4 M to 20.5 M (+0.15 %) |
| Mar 26 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 28.03 | 10,000 | 280,300 | 20,425,442 | 20.4 M to 20.4 M (+0.05 %) |
| Mar 26 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 28.61 | 90,000 | 2,574,900 | 20,415,442 | 20.3 M to 20.4 M (+0.44 %) |
| Mar 18 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 24.50 | 30,316 | 742,742 | 20,325,442 | 20.3 M to 20.3 M (+0.15 %) |
| Mar 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 26.80 | 30,000 | 804,000 | 20,295,126 | 20.3 M to 20.3 M (+0.15 %) |
| Mar 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 26.51 | 3,300 | 87,483 | 20,265,126 | 20.3 M to 20.3 M (+0.02 %) |
| Mar 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 26.45 | 16,700 | 441,715 | 20,261,826 | 20.2 M to 20.3 M (+0.08 %) |
| Mar 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 27.40 | 25,000 | 685,000 | 20,245,126 | 20.2 M to 20.2 M (+0.12 %) |
Page: 1